Biosimilar Trade Secrets: Coherus Hiring Of Amgen Exec Leads To Theft Suit

Three months before user fee date for Coherus' Neulasta (pegfilgrastim) biosimilar, Amgen claims company stole confidential information including pricing and contracting strategies.